Glow peptide 70mg
Original price was: £80.00.£75.00Current price is: £75.00.
🧬 Glow Peptide – 70mg Research Blend
-
🔬 GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
-
✅ ≥99% purity, HPLC tested
-
📦 10 vials included
-
💧 Free bacteriostatic water with every order
-
🧪 For laboratory research only
Order now – 10 vials + free Bac Water! 🚀
15% DISCOUNT ON CHECKOUT WITH CRYPTO
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Glow Peptide UK – 70mg Research Blend
Product Overview
Glow peptide UK research interest has grown rapidly as laboratories explore multi-pathway tissue-repair models. This 70mg research blend combines three complementary compounds: GHK-Cu (50mg) , BPC-157 (10mg) , and TB-500 (10mg) . This fixed-ratio formulation is studied for investigating collagen synthesis, angiogenesis, and cellular migration in parallel, reflecting how tissue-repair biology operates across multiple overlapping pathways. According to Velora Research, interest in multi-component peptide blends has increased substantially among UK laboratories over the past two years.
The formulation derives its name from the skin-focused research applications of its components. GHK-Cu (copper tripeptide-1) is the most extensively characterised component, studied for its effects on gene expression modulation and collagen synthesis. BPC-157 contributes angiogenesis-related mechanisms through VEGFR2 and nitric oxide signalling, as documented in research indexed by the NIH PubMed database. TB-500 (a synthetic fragment of Thymosin Beta-4) is investigated for actin regulation and cell migration.
When researchers in the UK source this blend, they often seek a single vial that provides all three mechanisms in a defined ratio, eliminating the need to reconstitute three separate compounds. Suppliers such as Durham Peptides note that the blue-tinted appearance reflects the copper coordination chemistry of GHK-Cu.
Regulatory Notice: This Glow peptide UK product is supplied strictly for laboratory research purposes only. It is not a medicine, cosmetic, or supplement. As reported by the Liverpool Echo, the MHRA has stated that it disregards “research purposes” claims if evidence suggests products are intended for human use, and will take regulatory action in such cases. None of the components hold MHRA marketing authorisation for human therapeutic use.
Product Specifications
| Feature | Specification |
|---|---|
| Product Name | Glow Peptide Blend |
| Composition | GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg |
| Total Peptide Content | 70mg per vial |
| GHK-Cu Sequence | Gly-His-Lys (Cu²⁺) |
| BPC-157 Sequence | GEPPPGKPADDAGLV |
| TB-500 Sequence | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES |
| Purity | ≥99% (HPLC) |
| Form | Lyophilized powder (blue-tinted) |
| Storage (Lyophilized) | -20°C, protected from light and moisture |
| For Research Use Only | Not for human or veterinary use |
Mechanism of Action
GHK-Cu – Collagen and Gene Expression Modulation
GHK-Cu is a naturally occurring copper-binding tripeptide studied for its role in collagen synthesis and extracellular matrix remodelling. Research indicates GHK-Cu modulates expression of hundreds of genes, including those related to collagen production, antioxidant response, and anti-inflammatory mediators. As explained by GhostLabz, the copper component is mechanistically essential—not decorative—and is involved in the peptide’s biological activity. In this blend, GHK-Cu represents the largest component by mass at 50mg.
BPC-157 – Angiogenesis and Growth Factor Signalling
BPC-157 (Body Protection Compound 157) is a 15-amino-acid pentadecapeptide studied for angiogenesis-related mechanisms through VEGFR2 and nitric oxide signalling pathways. Research interest centres on its potential role in delivering oxygen and nutrients to sites of tissue repair. BPC-157 is supplied at 10mg in this formulation.
TB-500 – Cell Migration and Actin Regulation
TB-500 is a synthetic fragment of Thymosin Beta-4, a 43-amino-acid actin-regulating protein. It is investigated for its effects on cell migration—the physical movement of fibroblasts, endothelial cells, and immune cells toward sites of repair. TB-500 is included at 10mg.
Synergistic Research Rationale
The blend combines three mechanisms that operate in parallel: copper-mediated gene modulation (GHK-Cu), angiogenesis signalling (BPC-157), and actin-driven cell migration (TB-500). Research protocols that benefit from investigating these pathways simultaneously often select this formulation rather than reconstituting three separate vials, for protocol consistency and cost efficiency.
Research Applications
Skin and Connective Tissue Research
The primary research focus is dermatological and connective tissue biology. GHK-Cu has documented effects on collagen and glycosaminoglycan synthesis in fibroblast culture, appearing extensively in dermatology research literature. The combination with BPC-157 and TB-500 extends the research scope to tissue-repair mechanisms that complement collagen-focused studies.
Collagen and Matrix Remodelling
GHK-Cu stimulates collagen synthesis—primarily Type I and Type III collagen, the structural proteins of skin and connective tissue. This makes the blend relevant for studies examining extracellular matrix composition and remodelling processes.
Multi-Pathway Tissue Repair
This formulation enables investigation of three distinct repair mechanisms within a single experimental system. BPC-157’s angiogenesis research and TB-500’s cell-migration research complement GHK-Cu’s collagen-focused activity, providing a broader view of tissue-repair biology than single-component studies.
Hair Follicle Research
GHK-Cu, the dominant component, is studied for hair-follicle size and growth factors tied to follicle activity. Research interest in GHK-Cu for hair biology exists independently of the other components, making this blend relevant for follicle-focused investigations.
Quality and Purity
Each batch of Cocer Peptides Glow peptide undergoes quality control aligned with research-grade standards:
-
≥99% purity verified by HPLC
-
Per-component identity confirmation
-
Batch/lot number matching the vial label
-
Certificate of Analysis (COA) available on request
According to Peptide Insider, a proper COA should address each component rather than the vial as a whole, with separate mass or percentage values for GHK-Cu, BPC-157, and TB-500. The lot number on the certificate must match the lot printed on the vial.
Frequently Asked Questions
What is the Glow peptide?
It is a 70mg research blend of GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg). It is studied for multi-pathway tissue-repair research, combining collagen synthesis, angiogenesis, and cell migration mechanisms in a single vial.
What is the difference between Glow peptide and Glow pen peptide?
Glow peptide refers to the lyophilized powder blend supplied in a standard vial. Glow pen peptide refers to the same blend supplied in a pre-filled injector pen format, which some suppliers such as Elysium Peptides and 123Peptide offer for laboratory dispensing consistency. Both are research-use-only materials.
How should this blend be stored?
Store lyophilized powder at -20°C, protected from light and moisture. The GHK-Cu component is light-sensitive, so dark storage is essential. Reconstituted material should be stored at 2–8°C and used promptly following standard laboratory protocols.
Is Glow peptide legal in the UK?
Research peptides are legal to buy, sell, and possess as materials for laboratory research in the UK. As noted by MY PEPTIDES, they are not controlled substances under the Misuse of Drugs Act 1971 and generally fall outside the Psychoactive Substances Act 2016. However, supplying them for human consumption or marketing with medical claims is unlawful.
What purity level can I expect?
Our blend is provided at ≥99% purity, verified by HPLC with batch-specific documentation.
Is this product suitable for human use?
No. This Glow peptide UK product is supplied strictly for research purposes only and is not intended for human or veterinary use. None of the components hold MHRA marketing authorisation for human therapeutic use.
Conclusion
The Glow peptide represents a multi-target research tool for investigating skin biology, collagen synthesis, and tissue-repair mechanisms. Its fixed-ratio composition of GHK-Cu, BPC-157, and TB-500 enables parallel investigation of three distinct pathways within a single experimental system. For UK researchers sourcing this blend for laboratory applications, it offers documented composition, ≥99% purity, and batch-specific COA support.
Ready to Advance Your Research?
Order the Glow peptide 70mg research blend for your laboratory today.






Reviews
There are no reviews yet.